Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

18 results
Display

The Author's Response: Assessment of Breast Cancer Patients' Knowledge and Decisional Conflict Regarding Tamoxifen Use

Kim SI, Lim MC, Lee ES

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prevalence and Characteristics of Chemotherapy-related Cognitive Impairment in Patients with Breast Cancer

Park JH, Bae SH, Jung YS, Jung YM

PURPOSE: Evidence suggests that some patients with breast cancer experience cognitive difficulties following chemotherapy. This longitudinal study was done to examine the prevalence of cognitive impairment and trajectory of cognitive...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Preventive Effects of Zoledronic Acid on Bone Metastasis in Mice Injected with Human Breast Cancer Cells

Jeong J, Lee KS, Choi YK, Oh YJ, Lee HD

Bisphosphonates are used routinely to reduce bone-related events in breast cancer patients with bone metastasis. We evaluated the effects of zoledronic acid, a third generation, nitrogen-containing bisphosphonate, to prevent bone...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Letter to the Editor: Patients' Knowledge and Decisional Conflict Regarding Tamoxifen Use: Scientific Views

Das S, Mahakkanukrauh P

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Meta-analysis of Chemotherapy related Cognitive Impairment in Patients with Breast Cancer

Park JH, Bae SH

PURPOSE: The purpose of this study was to evaluate the cognitive effects of chemotherapy in patients with breast cancer. METHODS: Using several databases, prospective studies were collected up to August 2011....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Development and Preliminary Evaluation of Psychometric Properties of Symptom-Management Self-Efficacy Scale for Breast Cancer Related to Chemotherapy

Liang SY, Wu WW, Kuo CY, Lu YY

PURPOSE: The purpose of this study was to develop and preliminarily evaluate the reliability and validity of the Symptom-Management Self-Efficacy ScaleeBreast Cancer (SMSES-BC) related to chemotherapy. METHODS: The study included three...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Capecitabine and Vinorelbine in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane

Ahn JH, Kim SB, Kim TW, Ahn SH, Kim SM, Park JM, Lee JS, Kang YK, Kim WK

We have evaluated the efficacy and safety of the combination of capecitabine and vinorelbine in metastatic breast cancer (MBC) patients previously treated with anthracycline-and taxane-containing regimens. Between April 2000 and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Therapy-related ALL with MLL Gene Rearrangement Following Treatment of Breast Cancer

Cho J, Hur M, Moon HW, Yun YM, Lee CH, Lee HG

ALL with MLL gene rearrangement secondary to chemotherapy has been rarely reported. We report a case of therapy-related ALL (t-ALL) with MLL gene rearrangement in a patient who had undergone...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effects of Foot Reflexology on Nausea, Vomiting and Fatigue of Breast Cancer Patients Undergoing Chemotherapy

Yang JH

  • KMID: 1754031
  • J Korean Acad Nurs.
  • 2005 Feb;35(1):177-185.
PURPOSE: The purpose of this study was to identify the effects of foot reflexology on nausea, vomiting and fatigue in breast cancer patients undergoing chemotherapy. METHOD: The research...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Phospholipase D inhibitor enhances radiosensitivity of breast cancer cells

Son JC, Kang DW, Yang KM, Choi KY, Son TG, Min DS

  • KMID: 2154257
  • Exp Mol Med.
  • 2013 Aug;45(8):e38.
Radiation and drug resistance remain the major challenges and causes of mortality in the treatment of locally advanced, recurrent and metastatic breast cancer. Dysregulation of phospholipase D (PLD) has been...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Structural Equation Model on Resilience of Breast Cancer Patients Receiving Chemotherapy

Yang JH, Kim OS

PURPOSE: The purpose of this study was to construct and test a structural equation model on resilience of breast cancer patients receiving chemotherapy. METHODS: Participants were 204 patients with breast cancer...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Assessment of Breast Cancer Patients' Knowledge and Decisional Conflict Regarding Tamoxifen Use

Kim SI, Lee Y, Son Y, Jun SY, Yun S, Bae HS, Lim MC, Jung SY, Joo J, Lee ES

Breast cancer is the most common type of female cancer. Tamoxifen, a selective estrogen receptor modulator, is widely used to decrease breast cancer recurrence and mortality among patients. However, it...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Feature of amenorrhea in postoperative tamoxifen users with breast cancer

Kim H, Han W, Ku SY, Suh CS, Kim SH, Choi YM

OBJECTIVE: Tamoxifen has been used to prevent the recurrence of breast cancer. However, tamoxifen-users frequently experience amenorrhea and it can be confused from that caused by other hormonal abnormalities. In...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Weekly Paclitaxel and Trastuzumab as a First-Line Therapy in Patients with HER2-Overexpressing Metastatic Breast Cancer: Magnitude of HER2/neu Amplification as a Predictive Factor for Efficacy

Han HS, Kim JS, Park JH, Jeon YK, Lee KW, Oh DY, Kim JH, Park SY, Im SA, Kim TY, Park IA, Bang YJ

We evaluated the efficacy and safety of weekly paclitaxel plus trastuzumab as firs-tline chemotherapy in women with HER2-overexpressing metastatic breast cancer (MBC), and we investigated the prognostic factors including magnitude...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of the Diagnostic Performance of Response Evaluation Criteria in Solid Tumor 1.0 with Response Evaluation Criteria in Solid Tumor 1.1 on MRI in Advanced Breast Cancer Response Evaluation to Neoadjuvant Chemotherapy

Jeh SK, Kim SH, Kang BJ

OBJECTIVE: To compare the diagnostic performance in evaluating the response of neoadjuvant chemotherapy (NAC), between the response evaluation criteria in solid tumor (RECIST) 1.0 and RECIST 1.1, on magnetic resonance...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Impacts of Tumor Cell Contamination of Hematopoietic Stem Cell Products in Metastatic Breast Cancer Patients undergoing Autologous Peripheral Blood Stem Cell Transplantation: Multicenter Trial

Ahn MJ, Noh YH, Lee YS, Lee YY, Choi IY, Kim IS, Joh EK, Shin DB, Kim SY, Cho KS, Kim HC, Kim HS, Suh CW, Kim SH, Lee JA, Park YS

To determine whether the tumor cell contamination of peripheral blood stem cells influences clinical impacts on high-dose chemotherapy in patients with metastatic breast cancer, we analyzed carcinoembryonic antigen (CEA) mRNA...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hepatitis B Reactivation During Adjuvant Anthracycline-Based Chemotherapy in Patients with Breast Cancer: A Single Institution's Experience

Kim MK, Ahn JH, Kim SB, Im YS, Lee SI, Ahn SH, Son BH, Gong G, Kim HH, Kim WK

BACKGROUND: The objectives of this study were to determine the incidence, outcome and risk factors for HBV reactivation in HBsAg positive breast cancer patients while on anthracycline -based adjuvant...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
High-dose Versus Low-dose Cyclophosphamide in Combination with G-CSF for Peripheral Blood Progenitor Cell Mobilization

Ahn JS, Park S, Im SA, Yoon SS, Lee JS, Kim BK, Bang SM, Cho EK, Lee JH, Jung CW, Kim HC, Seong CM, Lee MH, Kim CS, Lee KS, Lee JA, Ahn MJ

BACKGROUND: To compare the mobilizing effects and toxicities of two different doses of cyclophosphamide (CY) plus lenograstim (glycosylated G-CSF), we performed a prospective randomized study by enrolling patients suffering with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr